Erythromycin ethylsuccinate 40 MG/ML Oral Suspension — RxCUI 686400
RxNorm drug concept · Semantic clinical drug
RxCUI 686400
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI686400
Official nameErythromycin ethylsuccinate 40 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asEES 40 MG/ML Oral Suspension; erythromycin ethylsuccinate 200 MG in 5 mL Oral Suspension; erythromycin ethylsuccinate 200 MG per 5 ML Oral Suspension
FDA products mapped26
Package NDCs mapped26
Reported Medicaid activity (SDUD)51,495 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Erythromycin Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's used to treat bacterial infections on the surface of your eye — the conjunctiva (the clear membrane over the white part) and the cornea (the clear front surface). It's also us...
- What exactly does this eye ointment treat?
- Gently pull your lower eyelid down to create a small pocket, then squeeze a ribbon of ointment — about 1 cm, roughly the size of a grain of rice — into that pocket. Blink a few tim...
- How do I apply the ointment without making a mess?
🕸️ Concept Web — How Erythromycin ethylsuccinate 40 MG/ML Oral Suspen... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Erythromycin ethylsuccinate 40 MG/ML Oral Suspension
RxCUI 686400 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Erythromycin
4053IN -
Erythromycin ethylsuccinate
4056PIN
-
Erythromycin
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
E.E.S.
863600BN -
EryPed
203253BN
-
E.E.S.
-
Dose forms 17
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Erythromycin Oral Suspension
372062SCDF -
Erythromycin ethylsuccinate Oral Suspension
2648213SCDFP -
Erythromycin Oral Liquid Product
1164503SCDG -
Erythromycin Oral Product
1164504SCDG -
Erythromycin ethylsuccinate Oral Liquid Product
2663576SCDGP -
Erythromycin ethylsuccinate Oral Product
2662042SCDGP -
Erythromycin Oral Suspension [E.E.S.]
863602SBDF -
Erythromycin Oral Suspension [EryPed]
544533SBDF - +9 more in this family
-
Erythromycin Oral Suspension
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Erythromycin ethylsuccinate 40 MG/ML
686382SCDC -
Erythromycin ethylsuccinate 40 MG/ML Oral Suspension [E.E.S.]
863603SBD -
Erythromycin ethylsuccinate 40 MG/ML Oral Suspension [EryPed]
686402SBD -
Erythromycin ethylsuccinate 40 MG/ML [E.E.S.]
863601SBDC -
Erythromycin ethylsuccinate 40 MG/ML [EryPed]
686401SBDC
-
Erythromycin ethylsuccinate 40 MG/ML
Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Erythromycin ethylsuccinate 40 MG/ML
SCDC · 686382 -
Erythromycin Oral Suspension
SCDF · 372062 -
Erythromycin ethylsuccinate Oral Suspension
SCDFP · 2648213 -
Erythromycin Oral Liquid Product
SCDG · 1164503 -
Erythromycin Oral Product
SCDG · 1164504 -
Erythromycin ethylsuccinate Oral Liquid Product
SCDGP · 2663576 -
Erythromycin ethylsuccinate Oral Product
SCDGP · 2662042
Brand-Name Concepts
-
Erythromycin ethylsuccinate 40 MG/ML Oral Suspension [E.E.S.]
SBD · 863603 -
Erythromycin ethylsuccinate 40 MG/ML Oral Suspension [EryPed]
SBD · 686402 -
Erythromycin ethylsuccinate 40 MG/ML [E.E.S.]
SBDC · 863601 -
Erythromycin ethylsuccinate 40 MG/ML [EryPed]
SBDC · 686401 -
Erythromycin Oral Suspension [E.E.S.]
SBDF · 863602 -
Erythromycin Oral Suspension [EryPed]
SBDF · 544533 -
Erythromycin ethylsuccinate Oral Suspension [E.E.S.]
SBDFP · 2656934 -
Erythromycin ethylsuccinate Oral Suspension [EryPed]
SBDFP · 2656354 -
E.E.S. Oral Liquid Product
SBDG · 1171744 -
E.E.S. Oral Product
SBDG · 1171745
📦 FDA Products & Package NDCs
26 products · 26 package NDCs
26 package NDCs map to RxCUI 686400 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 24338-0100-03 | 30 TABLET in 1 BOTTLE (24338-100-03) | E.E.S 400 | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 2021-06-28 |
| 24338-0130-13 | 100 mL in 1 BOTTLE (24338-130-13) | Ery-Ped | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 2012-06-14 |
| 24338-0132-13 | 100 mL in 1 BOTTLE (24338-132-13) | Ery-Ped | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 2011-07-05 |
| 24338-0134-02 | 100 mL in 1 BOTTLE (24338-134-02) | E.E.S | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 2011-04-18 |
| 24338-0136-10 | 200 mL in 1 BOTTLE (24338-136-10) | E.E.S | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 2011-04-18 |
| 52536-0130-13 | 100 mL in 1 BOTTLE (52536-130-13) | ERYTHROMYCIN ETHYLSUCCINATE | Wilshire Pharmaceuticals | 2019-03-25 |
| 52536-0132-13 | 100 mL in 1 BOTTLE (52536-132-13) | ERYTHROMYCIN ETHYLSUCCINATE | Wilshire Pharmaceuticals | 2020-08-24 |
| 52536-0134-13 | 100 mL in 1 BOTTLE (52536-134-13) | Erythromycin Ethylsuccinate | Wilshire Pharmaceuticals Inc. | 2016-09-28 |
| 52536-0136-13 | 200 mL in 1 BOTTLE (52536-136-13) | Erythromycin Ethylsuccinate | Wilshire Pharmaceuticals Inc. | 2016-09-28 |
| 60219-1503-01 | 100 mL in 1 BOTTLE (60219-1503-1) | Erythromycin Ethylsuccinate | Amneal Pharmaceuticals NY LLC | 2023-12-02 |
| 60219-1504-02 | 100 mL in 1 BOTTLE (60219-1504-2) | Erythromycin Ethylsuccinate | Amneal Pharmaceuticals NY LLC | 2023-12-02 |
| 62559-0440-02 | 200 mL in 1 BOTTLE (62559-440-02) | Erythromycin Ethylsuccinate | ANI Pharmaceuticals, Inc. | 2016-09-27 |
| 62559-0630-01 | 100 mL in 1 BOTTLE (62559-630-01) | Erythromycin Ethylsuccinate | ANI Pharmaceuticals, Inc. | 2019-03-25 |
| 62559-0631-01 | 100 mL in 1 BOTTLE (62559-631-01) | Erythromycin Ethylsuccinate | ANI Pharmaceuticals, Inc. | 2019-03-25 |
| 69238-1503-01 | 100 mL in 1 BOTTLE (69238-1503-1) | Erythromycin Ethylsuccinate | Amneal Pharmaceuticals NY LLC | 2019-11-04 |
| 69238-1504-02 | 100 mL in 1 BOTTLE (69238-1504-2) | Erythromycin Ethylsuccinate | Amneal Pharmaceuticals NY LLC | 2019-11-04 |
| 71209-0102-21 | 100 mL in 1 BOTTLE (71209-102-21) | Erythromycin ethylsuccinate | Cadila Pharmaceuticals Limited | 2022-11-21 |
| 71209-0103-21 | 100 mL in 1 BOTTLE (71209-103-21) | Erythromycin ethylsuccinate | Cadila Pharmaceuticals Limited | 2022-11-21 |
| 72162-2657-01 | 100 mL in 1 BOTTLE (72162-2657-1) | Erythromycin ethylsuccinate | Bryant Ranch Prepack | 2026-06-05 |
| 75834-0294-01 | 100 mL in 1 BOTTLE (75834-294-01) | Erythromycin Ethylsuccinate | Nivagen Pharmaceuticals, Inc. | 2023-02-01 |
| 75834-0295-01 | 100 mL in 1 BOTTLE (75834-295-01) | Erythromycin Ethylsuccinate | Nivagen Pharmaceuticals, Inc. | 2023-02-01 |
| 80005-0152-18 | 100 mL in 1 BOTTLE (80005-152-18) | E.E.S | Carnegie Pharmaceuticals LLC | 2025-01-15 |
| 80005-0153-34 | 200 mL in 1 BOTTLE (80005-153-34) | E.E.S | Carnegie Pharmaceuticals LLC | 2025-01-15 |
| 80005-0161-08 | 30 TABLET in 1 BOTTLE (80005-161-08) | E.E.S 400 | Carnegie Pharmaceuticals LLC | 2025-01-15 |
| 85742-0029-28 | 100 mL in 1 BOTTLE (85742-029-28) | Erythromycin ethylsuccinate | Kanchan Healthcare Inc | 2022-11-21 |
| 85742-0030-28 | 100 mL in 1 BOTTLE (85742-030-28) | Erythromycin ethylsuccinate | Kanchan Healthcare Inc | 2022-11-21 |
Observed labelers:
Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) (5) ·
Amneal Pharmaceuticals NY LLC (4) ·
ANI Pharmaceuticals, Inc. (3) ·
Carnegie Pharmaceuticals LLC (3) ·
Cadila Pharmaceuticals Limited (2) ·
Kanchan Healthcare Inc (2)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.